They deliver strong results for many people, yet bring high prices, needles, and frequent side effects
Our team provides ongoing guidance, monitoring, and support to help patients build sustainable habits while working toward meaningful weight loss and improved overall health
None of those steps will be complete before late 2027 at the earliest
Research Use Disclaimer All compounds referenced are intended strictly for laboratory research use only
UK considerations NHS and MHRA guidance The UK health authorities have clear positions on weight loss treatments: The NHS offers GLP-1 medications through specialist weight management services for eligible patients MHRA has approved Wegovy, Saxenda, and Mounjaro based on comprehensive safety and efficacy data No GLP-1 patch products have received MHRA approval as weight loss treatments The MHRA has issued warnings about misleading claims in weight loss supplements Cost and access in the UK The financial aspect is a significant consideration for many: NHS provision : Limited availability through specialist weight management services with strict eligibility criteria Private prescriptions : 150-300 monthly, depending on medication and provider Commercial patches : 12-70 monthly, depending on brand and quantity While patches appear less expensive, they lack evidence of effectiveness, making them poor value regardless of price
Well assess your eligibility and craft a personalized treatment plan just for you
